Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Early balding at 40 increases prostate cancer risk.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Hsc70 protein may influence hair growth by responding to androgens.

We need better ways to test and understand SARMs to make safer and more effective treatments.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

High androgen levels can cause hirsutism and increase inflammation.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Gene variation affects prostate issues and hair loss.

Excess maternal androgens can cause heart problems in offspring.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.